Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Dec 13, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −7,000 | $7.54 | $52,780 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| May 20, 2024 | BioCryst Pharmaceuticals Inc. | Open-market purchase | +5,000 | $6.38 | $31,900 |
| Jun 14, 2023 | BioCryst Pharmaceuticals Inc. | Open-market sale | −12,866 | $8.04 | $103,443 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.